Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (42)

• A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system via openalex
• Atherosclerosis in women with endometriosis via openalex
• Atherosclerosis, Oxidation and Endometriosis via openalex
• Chronic Pelvic Pain via openalex
• Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis via openalex
• Elevated serum lipoprotein(a) levels in young women with endometriosis via openalex
• Estrogen ‘add‐back’ and lipid profile during GnRH agonist (triptorelin) therapy via openalex
• Expression of soluble adhesion molecules in sera of women with stage III and IV endometriosis via openalex
• Expression of Soluble Adhesion Molecules in Sera of Women With Stage III and IV Endometriosis via openalex
• Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
• Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease via openalex
• The use of biochemical markers in the diagnosis of pelvic endometriosis via openalex
• Zoladex versus Danazol in the Treatment of Pelvic Endometriosis: Effects on Plasma Lipid Risk Factors via openalex
• W2094977869 via openalex
• W2116404316 via openalex
• W2118310760 via openalex
• W2121311096 via openalex
• W2123134517 via openalex
• W2125652739 via openalex
• W2132440468 via openalex
• W2153760994 via openalex
• W2161974825 via openalex
• W2205351132 via openalex
• W2328794162 via openalex
• W2628053793 via openalex
• W4238251256 via openalex
• W4245564528 via openalex
• W4285719527 via openalex
• W200963969 via openalex
• W6608138635 via openalex
• W1850111682 via openalex
• W1968044557 via openalex
• W1968974976 via openalex
• W1975362336 via openalex
• W1987144846 via openalex
• W1997443963 via openalex
• W2018103511 via openalex
• W2019491044 via openalex
• W2058386687 via openalex
• W2066640428 via openalex
• W2067504868 via openalex
• W2070481169 via openalex

Cited by (32)

• The efficacy of progestins in managing pain associated with endometriosis, fibroids and pre-menstrual syndrome: a systematic review 2025
• Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
• A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
• Gonadotropin-releasing hormone analogues for endometriosis 2023
• A review of phase II and III drugs for the treatment and management of endometriosis 2023
• Advances in targeting estrogen synthesis and receptors in patients with endometriosis 2022
• Review Article on Evalution of Endometriosis Disorder 2021
• General practitioners and endometriosis: Level of knowledge and the impact of training 2021
• Revealing the enigma of coagulation in endometriosis: the risk of thrombosis and the role of antithrombotic treatment 2020
• Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis 2020
• A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
• Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS 2018
• Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis 2018
• Current and Emerging Therapeutics for the Management of Endometriosis 2018
• Current and emerging treatment options for endometriosis 2018
• Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care 2017
• Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques 2017
• Management of endometriosis‐related pelvic pain 2017
• Oral and depot progestin therapy for endometriosis: towards a personalized medicine 2017
• New paradigms in the diagnosis and management of endometriosis 2016
• Estrogen-progestins and progestins for the management of endometriosis 2016
• Endometriosis: A review of the diagnosis and pain management 2015
• The Impact of Endometriosis across the Lifespan of Women: Foreseeable Research and Therapeutic Prospects 2015
• Treatment of pain associated with deep endometriosis: alternatives and evidence 2015
• Benefícios não contraceptivos do Sistema Intrauterino Liberador de Levonorgestrel na endometriose 2015
• NONCONTRACEPTIVE BENEFITS OF LEVONORGESTREL- RELEASING INTRAUTERINE SYSTEM ON ENDOMETRIOSIS 2015
• Systematic review of endometriosis pain assessment: how to choose a scale? 2014
• Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis 2013
• Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2013
• Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel‐releasing intrauterine device 2011
• 异常在位子宫内膜是内异症的病因吗？-在位内膜在内异症发病中的作用 2011
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010

Source provenance

europepmc

last seen: 2026-06-04T01:30:01.192114+00:00

openalex

last seen: 2026-06-04T00:00:01.174412+00:00

pubmed

last seen: 2026-05-13T22:17:18.915199+00:00